The DIAGNOSE-CTE Research Project

Key facts

Sponsor

Boston University

Principal Investigator

Robert A Stern, PhD

Boston University

Enrollment

240 enrolled

Eligibility

45-74 years · MALE

Timeline

2016 – 2023

Study locations (1)

• Boston University School of Medicine, Boston, Massachusetts, United States

Collaborators

Mayo Clinic · Banner Health · Brigham and Women's Hospital · NYU Langone Health · The Cleveland Clinic · National Institute of Neurological Disorders and Stroke (NINDS)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Dementia pugilistica

Additional recruiting or active studies for the same condition.

• ENROLLING BY INVITATIONNCT07521384
  Real World Outcomes of Intranasal MuSE Exosomes and Stem Cells in Neurological Regenerative Therapy
  Healing Hope International
• RECRUITINGPHASE3NCT06254469
  Visualizing Brain Proteinopathies Using [F-18]Flornaptitril-PET in the Prediction of Clinical Progression of Mild Cognitive Impairment With Either Suspected Chronic Traumatic Encephalopathy or Alzheimer's Disease
  CereMark Pharma, LLC
• ENROLLING BY INVITATIONNCT06860828
  The DIAGNOSE CTE Research Project-II
  Boston University
• RECRUITINGNCT07302503
  Pilot Study Evaluating brainQuant's Ability to Detect Alterations in White Matter in Diffusion MRI, Indicative of Post-traumatic Lesions
  University Hospital, Strasbourg, France
• RECRUITINGNCT04124029
  Contributions of mTBI to Neurodegeneration Due to Chronic Traumatic Encephalopathy (CTE) and Alzheimer's Disease (AD)
  VA Office of Research and Development
• RECRUITINGNCT03218332
  Post-Concussion Syndrome in Professional Athletes: A Multidisciplinary Study
  University Health Network, Toronto

See all trials for Dementia pugilistica →